Found 10 matching trials
HAIC+Lenvatinib+Tislelizumab vs D-TACE+Lenvatinib+Tislelizumab for Unresectable HCC PHASE2 Drug-eluting Bead-Transarterial chemoembolization (D-TACE) is the most wide...
Show More Location
The Second Affiliated Hospital of Nanchang University
Learn More & Join Trial
Surgery Plus Systemic Therapy for Liver Cancer With Extrahepatic Metastases NA This study will evaluate whether resection of the primary liver tumor, in a...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Efficacy and Safety of Yttrium-90 Microspheres Selective Internal Radiotherapy Combined with Immune Checkpoint Inhibitors and Anti-angiogenesis Drugs Sequential HAIC for Hepatocellular Carcinoma PHASE2 To observe and evaluate the efficacy and safety of selective internal radio...
Show More Location
Multiple Locations
Learn More & Join Trial
HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416) N/A The purpose of this study is to evaluate the safety and efficacy of hepatic...
Show More Location
The first hospital of China medical university
Learn More & Join Trial
A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Targeted Therapy and a PD-1 Inhibitor in Patients With Postoperative Hepatocellular Carcinoma and Microvascular Invasion PHASE4 A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Sa...
Show More Location
The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC PHASE2 This is a prospective, single-center, single-arm clinical study. It aims to...
Show More Location
Multiple Locations
Learn More & Join Trial
A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold Regions N/A Hepatocellular carcinoma (HCC) is a common global malignancy. In China, the...
Show More Status
Active Not Recruiting
Location
Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin, Heilongjiang Province, China
Learn More & Join Trial
HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma N/A Intrahepatic cholangiocarcinoma (ICC) is associated with poor prognosis. Th...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed From Standard Systemic Treatment NA Hepatic arterial infuison chemothearpy (HAIC), targeted therapy, and progra...
Show More Location
Peking Univerisity Cancer Hospital
Learn More & Join Trial
TACE-HAIC Combined With TKIs and Immunotherapy Versus TACE Alone for Hepatocellular Carcinoma With PVTT N/A Hepatocellular carcinoma (HCC) is characterized with vascular invasion, par...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial